José Angel Delgado
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
José Angel Delgado has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Adrían Alfonso Hernández
Center of Biomaterials, University of Havana, Havan 10400, Cuba
2 shared publications - Amisel Almirall
Biomaterials Center, University of Havana, Avenida Universidad entre G y Ronda, Vedado, Plaza, La Habana 10400, Cuba
2 shared publications - Antonio H. De Aza
Instituto de Cerámica y Vidrio, CSIC, Madrid, Spain
2 shared publications Daniel Correa
Departamento de Cerámicas y Composites, Centro de Biomateriales, Universidad de La Habana, 10400, La Habana, Cuba
2 shared publications- Eduardo Mendizábal
CUCEI, University of Guadalajara, Jalisco, Mexico.
2 shared publications Juan Parra
Unidad de Investigación Clínica y Biopatología Experimental; Hospital Provincial de Ávila, Centro de Investigación en Red-Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN); Ávila Spain
2 shared publications
Latest Publications
- Open Access
- 9 August 2024
- Published by Elsevier in Materials Today Bio
- Vol. 28, 101187
Silica 3D printed scaffolds as pH stimuli-responsive drug release platform
- 9 August 2024
- Published by Elsevier in Materials Today Bio
- Vol. 28, 101187
Open AccessSilica 3D printed scaffolds as pH stimuli-responsive drug release platform
- Open Access
- 30 June 2019
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 13 (06) , 487-495
Antibacterial effect of acrylic bone cements loaded with drugs of different action’s mechanism
Introduction: Antibiotic-loaded bone cements of poly(methyl methacrylate) are considered as very useful biomaterials for the management of corporal deep osseous infections. However, the high prevalence of resistant germs and polymicrobial infections makes it necessary to search for new formulations of bone cements containing antibiotics for local antibacterial therapy. In this work, bone cements loaded with drugs with different mechanism of action were evaluated to determine its antibacterial effectiveness on Pseudomonas aeruginosa. Methodology: Poly(methyl methacrylate) cements loaded with 10 wt.% of Oleozon®, mixtures of Ciprofloxacin/Meropenem and Ciprofloxacin/Meropenem/Oleozon® were prepared. The in vitro drugs release in water was followed by UV-Vis spectroscopy, and their antibacterial activity against Pseudomonas aeruginosa was evaluated for 11 days using the microdilution method. Results: All the extracts demonstrated an inhibitory effect on the growth of the strain during the whole trial period. Extracts from cement with Oleozon® only presented a total antibacterial inhibitory effect during 20 hours for the extracts taken at day 1 while the extracts from the cements loaded with mixtures of Ciprofloxacin/Meropenem and Ciprofloxacin/Meropenem/Oleozon® showed complete inhibition of the growth of the microorganism, even at 11 days. At the end of the trial period, some of the drugs remained inside the matrices, indicating that they can be released for a longer time in treatments. Conclusions: The results indicated a positive antibacterial effect by the combined used of the two or the three drugs tested against the Gram-negative bacilli Pseudomonas aeruginosa, so these proposal may be a valid alternative to be considered by surgeons.
- 30 June 2019
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 13 (06) , 487-495
Open AccessAntibacterial effect of acrylic bone cements loaded with drugs of different action’s mechanism
Introduction: Antibiotic-loaded bone cements of poly(methyl methacrylate) are considered as very useful biomaterials for the management of corporal deep osseous infections. However, the high prevalence of resistant germs and polymicrobial infections makes it necessary to search for new formulations of bone cements containing antibiotics for local antibacterial therapy. In this work, bone cements loaded with drugs with different mechanism of action were evaluated to determine its antibacterial effectiveness on Pseudomonas aeruginosa. Methodology: Poly(methyl methacrylate) cements loaded with 10 wt.% of Oleozon®, mixtures of Ciprofloxacin/Meropenem and Ciprofloxacin/Meropenem/Oleozon® were prepared. The in vitro drugs release in water was followed by UV-Vis spectroscopy, and their antibacterial activity against Pseudomonas aeruginosa was evaluated for 11 days using the microdilution method. Results: All the extracts demonstrated an inhibitory effect on the growth of the strain during the whole trial period. Extracts from cement with Oleozon® only presented a total antibacterial inhibitory effect during 20 hours for the extracts taken at day 1 while the extracts from the cements loaded with mixtures of Ciprofloxacin/Meropenem and Ciprofloxacin/Meropenem/Oleozon® showed complete inhibition of the growth of the microorganism, even at 11 days. At the end of the trial period, some of the drugs remained inside the matrices, indicating that they can be released for a longer time in treatments. Conclusions: The results indicated a positive antibacterial effect by the combined used of the two or the three drugs tested against the Gram-negative bacilli Pseudomonas aeruginosa, so these proposal may be a valid alternative to be considered by surgeons.
- Open Access
- 11 April 2019
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (7) , 1790
Development, Characterization and In Vitro Biological Properties of Scaffolds Fabricated From Calcium Phosphate Nanoparticles
Ceramic materials mimic the mineral composition of native bone and feature osteoconductive properties; they are therefore used to regenerate bone tissue. Much research focuses on increasing the porosity and pore interconnectivity of ceramic scaffolds to increase osteoconductivity, cell migration and cell-cell interaction. We aimed to fabricate biocompatible 3D-scaffolds featuring macro- and microporous calcium phosphates with high pore interconnection. Nanoparticles of hydroxyapatite (HA) and calcium deficient hydroxyapatite (CDHA) were synthesized by wet chemical precipitation. Scaffolds were produced from them by the replication polymeric foam technique. Solid content and sintering temperature were varied. Nanoparticles and scaffolds were characterized regarding morphology, chemical and mineral composition, porosity and mechanical properties. Biocompatibility, cell attachment and distribution were evaluated in vitro with human adipose mesenchymal stem cells. Scaffolds with total porosity of 71%–87%, pores in the range of 280–550 µm and connectivity density up to 43 mm−3 were obtained. Smaller pore sizes were obtained at higher sintering temperature. High solid content resulted in a decrease of total porosity but increased interconnectivity. Scaffolds 50HA/50β-TCP featured superior interconnectivity and mechanical properties. They were bioactive and biocompatible. High HA solid content (40 wt.%) in the HA pure scaffolds was negative for cell viability and proliferation, while in the 50HA/50β-TCP composite scaffolds it resulted more biocompatible.
- 11 April 2019
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (7) , 1790
Open AccessDevelopment, Characterization and In Vitro Biological Properties of Scaffolds Fabricated From Calcium Phosphate Nanoparticles
Ceramic materials mimic the mineral composition of native bone and feature osteoconductive properties; they are therefore used to regenerate bone tissue. Much research focuses on increasing the porosity and pore interconnectivity of ceramic scaffolds to increase osteoconductivity, cell migration and cell-cell interaction. We aimed to fabricate biocompatible 3D-scaffolds featuring macro- and microporous calcium phosphates with high pore interconnection. Nanoparticles of hydroxyapatite (HA) and calcium deficient hydroxyapatite (CDHA) were synthesized by wet chemical precipitation. Scaffolds were produced from them by the replication polymeric foam technique. Solid content and sintering temperature were varied. Nanoparticles and scaffolds were characterized regarding morphology, chemical and mineral composition, porosity and mechanical properties. Biocompatibility, cell attachment and distribution were evaluated in vitro with human adipose mesenchymal stem cells. Scaffolds with total porosity of 71%–87%, pores in the range of 280–550 µm and connectivity density up to 43 mm−3 were obtained. Smaller pore sizes were obtained at higher sintering temperature. High solid content resulted in a decrease of total porosity but increased interconnectivity. Scaffolds 50HA/50β-TCP featured superior interconnectivity and mechanical properties. They were bioactive and biocompatible. High HA solid content (40 wt.%) in the HA pure scaffolds was negative for cell viability and proliferation, while in the 50HA/50β-TCP composite scaffolds it resulted more biocompatible.
- Open Access
- 20 October 2018
- Published by Universidad del Magdalena in Duazary
- Vol. 15 (3) , 347-353
Colocación de implante dental con relleno óseo Biograft-G® en hueso con trauma dentoalveolar. Reporte de caso
En la actualidad, para el odontólogo resulta un gran desafío poder restaurar la apariencia natural y la anatomía de dientes perdidos. En este trabajo se realiza el reporte de un caso clínico donde se restituye el incisivo central superior derecho, a causa de traumatismo dentomaxilofacial, por un implante Leader® combinado con el relleno óseo Biograft-G®. Se trata de una paciente de 19 años atendida en la consulta multidisciplinaria del Centro Nacional de Estomatología, La Habana, Cuba. La paciente portaba prótesis inmediata a causa de la pérdida del diente 11 por fractura de corona y raíz, con defecto óseo vestibular. A la paciente le ocurría fractura frecuente de la prótesis, viéndose afectada desde el punto de vista estético, social, psicoafectivo y funcional. Después de una evaluación multidisciplinaria y el consentimiento de la paciente, se procedió a la cirugía mediante la técnica de colgajo, colocación de implante Leader® y relleno con Biograft-G® para regenerar el defecto óseo, devolver contorno vestibular y lograr una rehabilitación definitiva. Con este tratamiento, la paciente obtuvo los resultados estéticos y funcionales deseados.
- 20 October 2018
- Published by Universidad del Magdalena in Duazary
- Vol. 15 (3) , 347-353
Open AccessColocación de implante dental con relleno óseo Biograft-G® en hueso con trauma dentoalveolar. Reporte de caso
En la actualidad, para el odontólogo resulta un gran desafío poder restaurar la apariencia natural y la anatomía de dientes perdidos. En este trabajo se realiza el reporte de un caso clínico donde se restituye el incisivo central superior derecho, a causa de traumatismo dentomaxilofacial, por un implante Leader® combinado con el relleno óseo Biograft-G®. Se trata de una paciente de 19 años atendida en la consulta multidisciplinaria del Centro Nacional de Estomatología, La Habana, Cuba. La paciente portaba prótesis inmediata a causa de la pérdida del diente 11 por fractura de corona y raíz, con defecto óseo vestibular. A la paciente le ocurría fractura frecuente de la prótesis, viéndose afectada desde el punto de vista estético, social, psicoafectivo y funcional. Después de una evaluación multidisciplinaria y el consentimiento de la paciente, se procedió a la cirugía mediante la técnica de colgajo, colocación de implante Leader® y relleno con Biograft-G® para regenerar el defecto óseo, devolver contorno vestibular y lograr una rehabilitación definitiva. Con este tratamiento, la paciente obtuvo los resultados estéticos y funcionales deseados.
- 25 April 2014
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 103 (1) , 72-83
α-Tricalcium phosphate cements modified withβ-dicalcium silicate and tricalcium aluminate: Physicochemical characterization,in vitrobioactivity and cytotoxicity
Biocompatibility, injectability and in situ self-setting are characteristics of calcium phosphate cements which make them promising materials for a wide range of clinical applications in traumatology and maxillo-facial surgery. One of the main disadvantages is their relatively low strength which restricts their use to nonload-bearing applications. α-Tricalcium phosphate (α-C3P) cement sets into calcium-deficient hydroxyapatite (CDHA), which is biocompatible and plays an essential role in the formation, growth and maintenance of tissue-biomaterial interface. β-Dicalcium silicate (β-C2S) and tricalcium aluminate (C3A) are Portland cement components, these compounds react with water to form hydrated phases that enhance mechanical strength of the end products. In this study, setting time, compressive strength (CS) and in vitro bioactivity and biocompatibility were evaluated to determine the influence of addition of β-C2S and C3A to α-C3P-based cement. X-ray diffraction and scanning electron microscopy were used to investigate phase composition and morphological changes in cement samples. Addition of C3A resulted in cements having suitable setting times, but low CS, only partial conversion into CDHA and cytotoxicity. However, addition of β-C2S delayed the setting times but promoted total conversion into CDHA by soaking in simulated body fluid and strengthened the set cement over the limit strength of cancellous bone. The best properties were obtained for cement added with 10 wt % of β-C2S, which showed in vitro bioactivity and cytocompatibility, making it a suitable candidate as bone substitute. © 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 72–83, 2015.
- 25 April 2014
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 103 (1) , 72-83
α-Tricalcium phosphate cements modified withβ-dicalcium silicate and tricalcium aluminate: Physicochemical characterization,in vitrobioactivity and cytotoxicity
Biocompatibility, injectability and in situ self-setting are characteristics of calcium phosphate cements which make them promising materials for a wide range of clinical applications in traumatology and maxillo-facial surgery. One of the main disadvantages is their relatively low strength which restricts their use to nonload-bearing applications. α-Tricalcium phosphate (α-C3P) cement sets into calcium-deficient hydroxyapatite (CDHA), which is biocompatible and plays an essential role in the formation, growth and maintenance of tissue-biomaterial interface. β-Dicalcium silicate (β-C2S) and tricalcium aluminate (C3A) are Portland cement components, these compounds react with water to form hydrated phases that enhance mechanical strength of the end products. In this study, setting time, compressive strength (CS) and in vitro bioactivity and biocompatibility were evaluated to determine the influence of addition of β-C2S and C3A to α-C3P-based cement. X-ray diffraction and scanning electron microscopy were used to investigate phase composition and morphological changes in cement samples. Addition of C3A resulted in cements having suitable setting times, but low CS, only partial conversion into CDHA and cytotoxicity. However, addition of β-C2S delayed the setting times but promoted total conversion into CDHA by soaking in simulated body fluid and strengthened the set cement over the limit strength of cancellous bone. The best properties were obtained for cement added with 10 wt % of β-C2S, which showed in vitro bioactivity and cytocompatibility, making it a suitable candidate as bone substitute. © 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 72–83, 2015.
- 26 November 2013
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 102 (10) , 3693-3703
β‐Dicalcium silicate‐based cement: Synthesis, characterization and in vitro bioactivity and biocompatibility studies
β-dicalcium silicate (β-Ca2SiO4, β-C2S) is one of the main constituents in Portland cement clinker and many refractory materials, itself is a hydraulic cement that reacts with water or aqueous solution at room/body temperature to form a hydrated phase (C-S-H), which provides mechanical strength to the end product. In the present investigation, β-C2S was synthesized by sol–gel process and it was used as powder to cement preparation, named CSiC. In vitro bioactivity and biocompatibility studies were assessed by soaking the cement samples in simulated body fluid solutions and human osteoblast cell cultures for various time periods, respectively. The results showed that the sol–gel process is an available synthesis method in order to obtain a pure powder of β-C2S at relatively low temperatures without chemical stabilizers. A bone-like apatite layer covered the material surface after soaking in SBF and its compressive strength (CSiC cement) was comparable with that of the human trabecular bone. The extracts of this cement were not cytotoxic and the cell growth and relative cell viability were comparable to negative control. © 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 3693–3703, 2014.
- 26 November 2013
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 102 (10) , 3693-3703
β‐Dicalcium silicate‐based cement: Synthesis, characterization and in vitro bioactivity and biocompatibility studies
β-dicalcium silicate (β-Ca2SiO4, β-C2S) is one of the main constituents in Portland cement clinker and many refractory materials, itself is a hydraulic cement that reacts with water or aqueous solution at room/body temperature to form a hydrated phase (C-S-H), which provides mechanical strength to the end product. In the present investigation, β-C2S was synthesized by sol–gel process and it was used as powder to cement preparation, named CSiC. In vitro bioactivity and biocompatibility studies were assessed by soaking the cement samples in simulated body fluid solutions and human osteoblast cell cultures for various time periods, respectively. The results showed that the sol–gel process is an available synthesis method in order to obtain a pure powder of β-C2S at relatively low temperatures without chemical stabilizers. A bone-like apatite layer covered the material surface after soaking in SBF and its compressive strength (CSiC cement) was comparable with that of the human trabecular bone. The extracts of this cement were not cytotoxic and the cell growth and relative cell viability were comparable to negative control. © 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 3693–3703, 2014.
- 1 January 2013
- Published by Springer Nature
- p. 116-119
Aplicaciones de los Vidrios de Fosfato de Calcio en el Desarrollo de Composites Bioactivos para la Sustitución del Tejido Óseo
- 1 January 2013
- Published by Springer Nature
- p. 116-119
Aplicaciones de los Vidrios de Fosfato de Calcio en el Desarrollo de Composites Bioactivos para la Sustitución del Tejido Óseo